Deferred Tax Assets, Valuation Allowance of Altimmune, Inc. from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Altimmune, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • Altimmune, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $127,141,000, a 19% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Altimmune, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $127,141,000 +$20,718,000 +19% 31 Dec 2025 10-K 06 Mar 2026 2025 FY
Q4 2024 $106,423,000 +$23,465,000 +28% 31 Dec 2024 10-K 06 Mar 2026 2025 FY
Q4 2023 $82,958,000 +$25,713,000 +45% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q4 2022 $57,245,000 +$16,661,000 +41% 31 Dec 2022 10-K 27 Mar 2024 2023 FY
Q4 2021 $40,584,000 +$21,912,914 +117% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q4 2020 $18,671,086 +$5,521,307 +42% 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q4 2019 $13,149,779 +$4,311,018 +49% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q4 2018 $8,838,761 -$4,831,463 -35% 31 Dec 2018 10-K 27 Mar 2020 2019 FY
Q4 2017 $13,670,224 +$3,814,413 +39% 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q4 2016 $9,855,811 -$58,752,590 -86% 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q4 2015 $68,608,401 -$67,632 -0.1% 31 Dec 2015 10-K 14 Mar 2017 2016 FY
Q4 2014 $68,676,033 +$2,450,624 +3.7% 31 Dec 2014 10-K 14 Mar 2017 2016 FY
Q4 2013 $66,225,409 +$2,443,581 +3.8% 31 Dec 2013 10-K 11 Mar 2016 2015 FY
Q4 2012 $63,781,828 -$202,419 -0.32% 31 Dec 2012 10-K 11 Mar 2015 2014 FY
Q4 2011 $63,984,247 31 Dec 2011 10-K 14 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.